Lonza Joins International Pharmaceutical Aerosol Consortium
Through this consortium, Lonza will collaborate with other industry leaders to advance the research and development of inhalation technologies
Through this consortium, Lonza will collaborate with other industry leaders to advance the research and development of inhalation technologies
Celerity Pharmaceuticals uses Biocon Biologics’ insulin drug substance to develop the product
The enhanced portfolio includes the Scenaria View, Supria series, The Echelon Smart and Arietta series
The test can overcome the time and cost limitations of traditional culture-based drug susceptibility testing as it can more rapidly detect all mutations known to be associated with drug resistance for any TB drug in one step
The investment will improve equipment efficiency and increase safety standards at its Lestrem site
Divsa's coverage across Central America bridges Barentz' leading positions in North and South America
Under the agreement, Lonza will deliver cGMP-standard drug substance for clinical supply
Over the next three years, BASF will continue to support Beyond Suncare by supplying the required raw materials free of charge and by providing technical expertise to further improve the formulation
The expansion reiterates BASF’s continued commitment to Asia Pacific and specifically to customers in the medical glove industry
DASH enables non-laboratory personnel to insert a nasal swab specimen directly into our test cartridge and then load the cartridge into the DASH instrument, providing an accurate result in about 15 minutes
Subscribe To Our Newsletter & Stay Updated